Risk of AF in cancer patients grows with intravenous bisphosphonate therapy - - ModernMedicine
Links shared publicly online about this topic.
- 733total visits
Risk of AF in cancer patients grows with intravenous bisphosphonate therapy - - ModernMedicine
Older cancer patients who receive intravenous bisphosphonate therapy may be at a modestly increased risk for atrial fibrillation, supraventricular tachycardia, and stroke, according to research published online Oct. 12, 2010 in the Journal of Clinical Oncology, as HealthDay News reported.
View full resource at modernmedicine.com
Tags: Heart Disease, Tachycardia, Arrhythmia, Supraventricular Tachycardia, Atrial Fibrillation, Cancer
Most Recently Shared on November 12, 2010 at 8:01 am By:
Risk of AF in cancer patients grows with intravenous bisphosphonate therapy: Older cancer patients who receive i... http://bit.ly/ajnF9m
Advertisement
